Clinical characteristics and outcome of healthcare associated pneumonia in Turkey

Gündüz, Canan; Taşbakan, Mehmet Sezai; Sayıner, Abdullah; Çilli, Aykut; Kılınç, Oğuz; Coşkun, Ayşın Şakar

doi:10.5578/tt.26423

Cited by 3 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All studies comparing HCAP and CAP patients confirmed differences with regard to older age and higher comorbidity. Three retrospective studiesdone from Korea [17], one from China [18] and one from Turkey [19]dprovided further general descriptions of HCAP populations. Otherwise, clinical characteristics were similar to those described in the original reports [2e6].…”

Section: Clinical Characteristicsmentioning

confidence: 99%

Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019?

Ewig

Kolditz

Pletz

et al. 2019

Clinical Microbiology and Infection

View full text Add to dashboard Cite

Background: There is an ongoing controversy on the role of the healthcare-associated pneumonia (HCAP) label in the treatment of patients with pneumonia. Objective: To provide an update of the literature on patients meeting criteria for HCAP between 2014 and 2018. Sources: The review is based on a systematic literature search using PubMed-Central full-text archive of biomedical and life sciences literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM). Content: Studies compared clinical characteristics of patients with HCAP and community-acquired pneumonia (CAP). HCAP patients were older and had a higher comorbidity. Mortality rates in HCAP varied from 5% to 33%, but seemed lower than those cited in the initial reports. Criteria behind the HCAP classification differed considerably within populations. Microbial patterns differed in that there was a higher incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, and, to a lesser extent, enterobacteriaceae. Definitions and rates of multidrug-resistant (MDR) pneumonia also varied considerably. Broad-spectrum guideline-concordant treatment did not reduce mortality in four observational studies. The HCAP criteria performed poorly as a predictive tool to identify MDR pneumonia or pathogens not covered by treatment for CAP. A new score (Drug Resistance in Pneumonia, DRIP) outperformed HCAP in the prediction of MDR pathogens. Comorbidity and functional status, but not different microbial patterns, seem to account for increased mortality. Implications: HCAP should no longer be used to identify patients at risk of MDR pathogens. The use of validated predictive scores along with implementation of de-escalation strategies and careful individual assessment of comorbidity and functional status seem superior strategies for clinical management.

show abstract

Section: Clinical Characteristicsmentioning

confidence: 99%

Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019?

Ewig

Kolditz

Pletz

et al. 2019

Clinical Microbiology and Infection

View full text Add to dashboard Cite

show abstract

“…In immunocompromised patients with CAP, Enterobacteriaceae spp., Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and extended-spectrum beta-lactamase positive are more frequent [75]. The study by Gunduz et al [76] conducted in Turkey between 2009 and 2013 observed that the causative bacteria isolated most fre-quently in patients with CAP are S. pneumoniae, P. aeruginosa,Escherichia coli, Haemophilus influenzae, S. aureus, Klebsiella pneumoniae, Streptococcus spp. and Moraxella catarrhalis.…”

Section: 22mentioning

confidence: 99%

The Prevalence of Chest Infection in Patients with Heart Failure in Al-Wahadah Teaching Hospital, Dhamar, Yemen

Al-Huthi¹,

Jayed²,

Salah³

2023

ijcsrr

View full text Add to dashboard Cite

Background: Heart failure is a common clinical manifestation of most organic heart diseases that progress to the end stage. Patients with heart failure are often accompanied by secondary conditions such as pulmonary circulatory congestion and pulmonary edema, which can lead to dyspnea, gas exchange disorders, and other consequences, creating certain conditions for pathogens to invade and colonize the lungs. Therefore, patients with heart failure may have higher risk of pulmonary infection. Aim: This study aimed to assess the prevalence of chest infection among patients with heart failure and to determine the characteristics of the patients with heart failure who had chest infection and the potential risk factors. Methods: A retrospective, descriptive cross-sectional study was carried out at internal medicine department, Al-Wahdah Teaching Hospital, Dhamar, Yemen over six months (June – December 2022). A total of 100 patients were enrolled in our study. A semi-structured questionnaire was designed and used for data collection. Results: A total of 100 heart failure patients including 53 (53%) males, and 47 (47%) females were successfully enrolled in this study. The majority of participated patients were of age group 40 – 60 years (55%), and were of rural residence (83%). Chest infection was documented in approximately two-thirds of included patients (63%). Chest infection was documented in majority of patients who were smokers, Qat chewer, shamma intakes, being obese, had cardiomyopathy, as well as those patients who had dyspnea of NYHA class III & IV, orthopnea, PND, productive cough, high sputum amount, whitish sputum color, peripheral chest pain, fatigue, sweating, fever and high WBC count, such associations were significant statistically. Conclusion: This study revealed that, chest infection in heart failure patients was common with overall prevalence of (63%) among included patients this study was. Based on this, an early prevention and intervention measures should be taken to reduce pulmonary infections in patients with heart failure.

show abstract

“…In immunocompromised patients with CAP, Enterobacteriaceae spp., Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and extended-spectrum beta-lactamase positive are more frequent (15). The study by Gunduz et al (16) conducted in Turkey between 2009 and 2013 observed that the causative bacteria isolated most frequently in patients with CAP are S. pneumoniae, P. aeruginosa, Escherichia coli, Haemophilus influenzae, S. aureus, Klebsiella pneumoniae, Streptococcus spp. and Moraxella catarrhalis.…”

Section: Causative Microorganismsmentioning

confidence: 99%

Community-Acquired Pneumonia in Adults: What’s New Focusing on Epidemiology, Microorganisms and Diagnosis?

Romero¹,

Rello²

2018

Erciyes Med J

View full text Add to dashboard Cite

Community-acquired pneumonia (CAP) is one of the most common causes of hospital admissions and death worldwide. The incidence and mortality of CAP are associated with the presence of comorbidities and increasing age. Streptococcus pneumoniae is the most frequent causative microorganism of CAP, although in many patients with CAP, the causative microorganism remains unknown. Currently, antimicrobial resistance is increasing, so the accurate diagnosis and determination of the causative microorganism are even more important. This is a key point in reducing both morbidity and mortality from CAP, and appropriate antimicrobial stewardship is now a global priority. This review summarizes on the epidemiology, microbiological etiology, and diagnosis of CAP in adults.

show abstract

Clinical characteristics and outcome of healthcare associated pneumonia in Turkey

Cited by 3 publications

References 18 publications

Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019?

Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019?

The Prevalence of Chest Infection in Patients with Heart Failure in Al-Wahadah Teaching Hospital, Dhamar, Yemen

Community-Acquired Pneumonia in Adults: What’s New Focusing on Epidemiology, Microorganisms and Diagnosis?

Contact Info

Product

Resources

About